The Robert Larner College of Medicine at the University of Vermont is an American medical school located in Burlington, Vermont on the campus of the University of Vermont. Established in 1822, it is the nation's seventh oldest medical school.

During the past decade, University of Vermont, College of Medicine conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 45 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 26 clinical trials were completed. i.e. 1300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Vermont, College of Medicine" #1 sponsor was "University of Vermont" with 14 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Children's Oncology Group" with 12 trials sponsored, "National Cancer Institute (NCI)" with 12 trials sponsored and "Alliance for Clinical Trials in Oncology" with 12 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Vermont, College of Medicine" #1 collaborator was "National Cancer Institute (NCI)" with 37 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 4 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Biologics, Inc." with 1 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "University of Vermont, College of Medicine" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Acute Respiratory Failure" (5 trials), "Breast Cancer" (4 trials) and "Acute Myeloid Leukemia" (3 trials). Many other conditions were trialed in "University of Vermont, College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Vermont, College of Medicine" are "Drug" (48 trials), "Other" (38 trials), "Biological" (15 trials), "Device" (13 trials) and "Procedure" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (27 trials), "Etoposide" (7 trials), "Pharmacological Study" (7 trials), "Cyclophosphamide" (6 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "University of Vermont, College of Medicine" are 72 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Vermont, College of Medicine". undefined are not yet recruiting, 4 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 48 completed trials in University of Vermont, College of Medicine, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of Vermont, College of Medicine, 7 "Phase 1" clinical trials were conducted, 30 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".